Clinical Trials / Research Studies
Neurofibromatosis NF2

Brain and Spinal Tumors Research Studies

< Back to Young Adult Cancer Research Studies Page

Neurofibromatosis NF2

SEL-TH-1601: Phase 2 Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

PURPOSE: In this research study the researchers want to learn more about the effects (both good and bad) the study drug selumetinib has on participants with neurofibromatosis type II (NF2) related tumor. The researchers are asking patients with NF2 related tumors to be in the study, because their he ...More